From: Impact of lipodystrophy on health-related quality of life: the QuaLip study
 | Baseline (V1) (n = 67) | Month 3 (V2) (n = 60) | Month 6 (V3) (n = 64) | Month 9 (V4) (n = 64) | Year-1 (V5) (n = 60) | Month 15 (V6) (n = 58) | Month 18 (V7) (n = 59) | Month 21 (V8) (n = 57) | Year-2 (V9) (n = 56) |
---|---|---|---|---|---|---|---|---|---|
EQ-5D 5L | |||||||||
VAS score < 60, n | 20 | 26 | 26 | 25 | 28 | 27 | 26 | 24 | 21 |
VAS score < 60, % | 29.85 | 43.33 | 40.63 | 39.06 | 46.67 | 46.55 | 44.07 | 42.11 | 37.50 |
BDI | |||||||||
Median | 16.00 | 17.50 | 16.50 | 13.50 | 12.50 | 15.50 | 13.00 | 17.00 | 12.50 |
25 percentiles | 7.00 | 9.00 | 8.00 | 06.00 | 6.00 | 6.75 | 5.00 | 5.00 | 5.00 |
75 percentiles | 24.00 | 26.75 | 26.00 | 29.25 | 26.75 | 29.00 | 26.00 | 27.50 | 25.75 |
Facit Fatigues score | |||||||||
Median | 27.00 | 25.00 | 26.50 | 30.50 | 32.50 | 31.50 | 33.00 | 33.00 | 28.00 |
25 percentiles | 17.00 | 17.25 | 15.00 | 16.25 | 18.00 | 14.75 | 17.00 | 18.50 | 17.00 |
75 percentiles | 38.00 | 39.00 | 40.75 | 41.00 | 40.75 | 41.25 | 40.00 | 44.00 | 45.00 |